Conference: New Understanding Of Genetic Haemochromatosis

CPD Accreditation Logo

This event was CPD accredited 5 Units

This event was held on Friday 31 March 2017. 

The Haemochromatosis Society was delighted to run a specialist one-day scientific/medical CPD accredited conference exploring and debating new understandings of the pathology, diagnosis and management of genetic haemochromatosis.

This important event, the first for many years in the UK focusing on genetic haemochromatosis, encompassed discussions on:

  • The role of transferrin saturation as a diagnostic and monitoring tool
  • Arthropathy and haemochromatosis (The Fernau Lecture)
  • MRI technology in the diagnosis of iron overload
  • Advances in our understanding of the genetics of haemochromatosis

The event, New Understanding of Genetic Haemochromatosis, was held on 31 March 2017 in central Birmingham and was aimed at clinicians and scientists alike, including haematologists, gastroenterologists, hepatologists, rheumatologists, general practitioners, venesection clinicians and others with an interest in the pathology of iron overload.


CPD accreditation was approved for 5 units (hours) of education time by The Royal College of Pathologists. Delegates in career grade posts who were enrolled with one of the Royal Colleges for CPD purposes were entitled to these credits.


A bursary scheme enabled students of relevant disciplines and clinicians on lower pay grades to secure places at the event at a 50% discount.


The venue for the event was the Novotel Hotel and Conference Centre, Broad Street, Birmingham, a modern conference venue with all the usual facilities.


0900 Coffee and registration
1000 – 1015 Welcome

Mr Howard Don, Chair, The Haemochromatosis Society

Introductions and Conference Chair’s Opening Remarks

Dr Edward (Ted) Fitzsimons
Event Chair
Consultant Haematologist, NHS Greater Glasgow & Clyde, Glasgow, Scotland
Honorary Clinical Associate Professor (School of Medicine, Dentistry and Nursing), University of Glasgow

1015 – 1115 The Role of Transferrin Saturation in the Pre-emption, Diagnosis and Management of Genetic Haemochromatosis: Contrasting Views and Debate

Prof. Pierre Brissot
Professor of Hepatology
Former head of the French Reference Center for Rare Genetic Iron Overload Diseases
University Hospital, Pontchaillou, Rennes, France

Prof. John Porter
Professor of Haematology and Consultant Haematologist
University College London Hospitals, London, UK
Head of the Joint Red Cell Unit for UCLH and Whittington Hospitals

1115 – 1130 Comfort Break
1130 – 1215 The Fernau Lecture (Inaugural)

The Fernau Lecture is given in honour of the founders of The Haemochromatosis Society, Mr Guy and Mrs Janet Fernau. This inaugural lecture was entitled “Arthropathy as a marker for the early diagnosis of genetic haemochromatosis – a patient study”

Dr Patrick Kiely BSc MB BS FRCP PhD
Consultant Rheumatologist
St George’s Healthcare NHS Trust, St George’s Hospital, London, UK

Followed by a Q&A opportunity

1215 – 1315 Lunch
1315 – 1445 MRI Technology and Genetic Haemochromatosis

The Development of MRI technology as applied to Genetic Haemochromatosis

Prof. Tim St Pierre BSc PhD
University of Western Australia, Perth, Australia
Chief Medical Officer
Resonance Healthcare, Perth, Australia

The Clinical Application of MRI technology

Dr Barbara Butzeck
Consultant Radiologist, Groenemeyer-Institut, Bochum, Germany

The impact of MRI Technology as a Diagnostic Tool in GH

Dr Rajarshi Banerjee
Chief Executive, Perspectum Diagnostics

1445 – 1515 Tea Break
1515 – 1615 The Digenic / Multigenic Nature of Iron Overload: Thinking Beyond C282Y and H63D

Dr Kathryn Robson and Dr Patricia Bignell
Weatherall Institute of Molecular Medicine, Oxford University

The GH Patient Pathway Through the NHS Blood Service

Dr Naim Akhtar
Clinical Support Team, NHS Blood & Transplant

1615 – 1645 Questions and Answers to the Speakers
Chair’s Closing Remarks and Summary
Dr Edward (Ted) Fitzsimons, Event Chair
1645 Event Close
1645 – 1800 Drinks Reception

Commercial Sponsorship

We are grateful for financial support from Resonance Health who made a contribution to the administrative costs of the conference and funded expenses for speakers Prof. Tim St Pierre and Dr Barbara Butzek.

We are grateful for financial support from Perspectum Diagnostics who kindly funded the bursary scheme described above.

At the time of writing there is no other financial relationship between either company and The Haemochromatosis Society.